-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Breast MRI screening is clinically important for concealed, early-stage, and biologically aggressive breast cancer in women with a personal history of breast cancer (PHBC
Abbreviated breast MRI reduces the time to scan and interpret compared to full-procedure breast MRI, increasing MRI accessibility while reducing costs
Recently, a study published in the journal Radiology adjusted for confounding variables by using propensity score matching to compare the results of abbreviated breast MRI with full-protocol MRI in women with PHBC, providing technical support
This study enrolled women with PHBC who
A total of 726 women were assigned to each MRI group (the average age of both groups ± SD, 50 years ± 8 years
This preference score matching cohort study showed that abbreviated breast MRI had considerable sensitivity and superior specificity compared to full-protocol breast MRI, with most detected breast cancers (93% of 14 out of 15) being nodulous-negative T1 aggressive cancers or ductal carcinoma in situ; Therefore, a shorter MRI can replace a full-protocol MRI scan when performing MRI screening in women with a personal history of breast cancer due to its short scan time, becoming one of the important steps in
Original source:
Soo-Yeon Kim,Nariya Cho,Hyunsook Hong,et al.